CN106397547A - 一种牛呼吸道胞合体病毒抗原蛋白 - Google Patents
一种牛呼吸道胞合体病毒抗原蛋白 Download PDFInfo
- Publication number
- CN106397547A CN106397547A CN201611064350.XA CN201611064350A CN106397547A CN 106397547 A CN106397547 A CN 106397547A CN 201611064350 A CN201611064350 A CN 201611064350A CN 106397547 A CN106397547 A CN 106397547A
- Authority
- CN
- China
- Prior art keywords
- ser
- val
- leu
- asn
- ile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明公开了一种牛呼吸道胞合体病毒抗原蛋白,所述牛呼吸道胞合体病毒抗原蛋白的氨基酸序列相比SEQ AAL49410.1至少有两个位点被半胱氨酸替代,且替代后的半胱氨酸之间由二硫键连接,在此基础上又进行内二硫键、空穴填充和单链连接等改进,同时提供了此类抗原蛋白的制备方法。该抗原蛋白应用蛋白质晶体学的技术和理论,确定蛋白在病毒侵染和致病过程中的结构变化,再根据结构变化的结果对这个关键的病毒蛋白进行基因工程改造,使其成为只侵染不致病、并引起动物体抗体高效反应的蛋白抗原,能够有效的预防和治疗牛呼吸道胞合体病毒感染,以此为基础可以开发出理想的病毒疫苗,有效控制和防范病毒感染带来的损失,具有重大的经济意义和社会意义。
Description
技术领域
本发明属于生物产品制备技术领域,涉及一种牛呼吸道胞合体病毒抗原蛋白及其制备方法。
背景技术
牛呼吸道胞合体病毒(Bovine Respiration Syncytial Virus – BRSV)感染可引起牛呼吸道疾病,在欧共体国家被列为仅次于牛粘膜病(BVD)及牛传染性鼻气管炎(IBR)的重要牛病之一。本病呈世界范围性流行,其危害性在于BRSV感染发病率高达到60%-80%,死亡率在一些爆发中达到20%以上,给养牛业造成很大的经济损失。虽然这种BRSV从上个世纪70年代就开始列入研发范畴,由于种种原因并没有开发出理想的药物和疫苗。尽管已有关于BRSV的多种灭活,弱毒,重组以及DNA疫苗的报道,但距离临床使用还有一定距离,目前国际上尚没有理想的病毒疫苗。
传统疫苗的研制和生产主要是通过改变培养条件,或在不同寄主动物上传代使致病微生物毒性减弱,或通过物理、化学方法将其灭活来完成的。随着人类知识的不断进步,传统疫苗的局限性也日益显露出来:(1)动物和人类的病毒需要在动物细胞中培养,这使得疫苗生产的成本很高;(2)疫苗中的致病物质在疫苗生产过程中有可能没有完全杀死或充分减毒,这会导致疫苗中含有强毒性致病物质,进而使得疾病在更大的范围内传播;(3)减毒菌株有可能会发生突变,引起病害。
施一公开创了中国结构生物学基础理论研究的先河,本发明将结构生物学应用到实际中,合成牛呼吸道胞合体病毒抗原蛋白。牛呼吸道胞合体病毒是副黏液病毒科家族的成员,其上的F-蛋白是高度保守的并形成三聚体刺突,其在激活下发生构象变化。F-蛋白介导病毒和细胞膜的融合,让病毒核壳体进入细胞质,抑制F-蛋白介导的步骤阻抑感染周期的起始阶段并中和病毒感染性可以有效的防止病毒侵害,即针对F-蛋白的抗体,抑制它的活性,可以中和病毒感染性并可以保护免受BRSV 感染。施一公开创了中国结构生物学基础理论研究的先河,本发明将结构生物学应用到实际中,合成牛呼吸道胞合体病毒抗原蛋白。
发明内容
本发明的目的在于克服现有技术存在的缺点,提供一种牛呼吸道胞合体病毒抗原蛋白及其制备方法,该抗原蛋白应用蛋白质晶体学的技术和理论,确定蛋白在病毒侵染和致病过程中的结构变化,再根据结构变化的结果对这个关键的病毒蛋白进行基因工程改造,使其成为只侵染不致病、并引起动物体抗体高效反应的蛋白抗原。
为了实现上述目的,本发明解决其技术问题所采取的技术方案是:
一种牛呼吸道胞合体病毒抗原蛋白,编码牛呼吸道胞合体病毒关键蛋白F-蛋白野生种的氨基酸序列简称SEQ AAL49410.1,具体序列为MRMIISIILISTYVPHITLCQNITEEFYQSTCSAVSRGYLSALRTGWYTSVVTIELSKIQKNVCNGTDSKVKLIKQELERYNNAVVELQSLMQNEPTSSSRAKRGIPESIHYTRNSTKKFYGLMGKKRKRRFLGFLLGIGSAIASGVAVSKVLHLEGEVNKIKNALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDKELLPKVNNHDCRISNIATVIEFQQKNNRLLEIAREFSVNAGITTPLSTYMLTNSELLSIINDMPITNDQKKLMSSNVQIVRQQSYSIMSVVKEEVIAYVVQLPLYGVIDTPCWKLHTSPLCTTDNEEGSNICLTRTDRGWYCDNAGSVSFFPQAETCKVQSNRVFCDTMNSLTLPTDVNLCNTDIFNAKYDCKIMTSKTDISSSVITSIGAIVSCYGKTKCTASNKNRGIIKTFSNGCDYVSNKGVDTVSVGNTLYYVNKLEGKALYIKGEPIINYYNPLVFPSDEFDASIAQVNAKINQSLAFIRRSDELLHSVDVGKSTTNVVITTIIIVIVVVILMLITVGLLFYCKTRSTPIMLGKDQLSSINNLSFSK,其特征在于:所述牛呼吸道胞合体病毒抗原蛋白的氨基酸序列相比SEQ AAL49410.1至少有两个位点被半胱氨酸替代,且替代后的半胱氨酸之间由二硫键连接。
作为优化的,所述位点为氨基酸序列第148位缬氨酸和288位异亮氨酸。
作为优化的,所述位点为氨基酸序列第158位亮氨酸和290位丝氨酸。
作为优化的,所述牛呼吸道胞合体病毒抗原蛋白的氨基酸序列相比SEQAAL49410.1,在第260位点的亮氨酸由半胱氨酸替代,并在该位点实现空穴填充。
作为优化的,所述针对牛呼吸道胞合体病毒抗原蛋白的氨基酸序列剔除SEQAAL49410.1序列中的103位点至138位点的氨基酸序列,采用sgsgs连接102位点和139位点。
作为优化的,所述针对牛呼吸道胞合体病毒抗原蛋白的氨基酸序列剔除SEQAAL49410.1序列中的103位点至142位点的氨基酸序列,采用sgsgs连接102位点和143位点。
作为优化的,所述编码牛呼吸道胞合体病毒抗原蛋白的氨基酸序列相比SEQAAL49410.1序列,第99位点天冬氨酸由半胱氨酸替代,第362位点丝氨酸由半胱氨酸替代,并在替代后的半胱氨酸之间连接内二硫键。
一种牛呼吸道胞合体病毒抗原蛋白的制备方法,其特征在于:具体工艺如下:
(1)根据结构生物学的原理,进行蛋白结晶,结晶后用X-射线观测,确定侵染病毒关键病原F-蛋白侵染前后的结构变化;
(2)根据步骤(1)结构变化设计出抗原蛋白的序列和结构;
(3)经多种抗原测试和稳定性特性检测确定出需要抗原蛋白的合格性;
(4)将经过验证的抗原蛋白序列进行相应的蛋白合成、表达、提纯和检测,得到用来作为动物试验和临床试验的针对牛呼吸道胞合体病毒抗原蛋白。
牛胞合体病毒关键F-蛋白介导病毒和细胞膜的融合,让病毒核壳体进入细胞。针对牛呼吸道胞合体病毒设计的抗原蛋白,便是根据F-蛋白侵染前后的结构变化设定的,在基因工程的基础上使F-蛋白结构始终保持在融合前的状态,使其具有只侵染不致病、并引起动物体抗体高效反应的蛋白抗原等特点。
本发明能够使F-蛋白在侵染前后都保持三聚体刺突状态(闭合状态),得到只侵染不致病、并引起动物抗体高效反应的蛋白抗原;为了保证来自于病原病毒上的F-蛋白处在稳定的侵染前的状态,给F-蛋白上增添了系列的连接链,包括内二硫键、二硫键、空穴填充和单链连接。
本发明与现有技术相比,其有益效果是:采用蛋白质晶体学方法制备的牛呼吸道胞合体病毒抗原蛋白能够有效的预防和治疗牛呼吸道胞合体病毒感染,以此为基础可以开发出理想的病毒疫苗;有效控制和防范病毒感染带来的损失,具有重大的经济意义和社会意义。
附图说明
图1 本发明涉及利用Phenix软件进行牛合胞体病毒F-蛋白的三维立体结构模拟图,左图为浸染前三聚体三维立体结构模拟图,右图为左图右下角方框位置的局部放大图。
图2 本发明涉及的牛合胞体病毒呼吸道病毒侵染前后过程的关键的F-蛋白结构变化示意图。在图中显示侵染前(左),F-蛋白三聚体呈现三聚体刺突状态,侵染后(右)F-蛋白被激活,发生构象变化,病毒和细胞膜的融合,病毒核壳体进入细胞质,进而侵染牛体并使其致病。
图3 本发明涉及的经过改造成功的牛呼吸道胞合体蛋白抗原侵染牛体后的电镜照片状态。左图显示RD-BRSV-DB1-CF1改造的牛呼吸道胞合体蛋白抗原侵染牛体后的状态,可见呈现稳定的融合前三聚体刺突状态,右图为未经过改造的牛呼吸道胞合体病毒侵染牛体后的电镜照片。
图4 本发明涉及的F-蛋白上添加连接链示意图,包括内二硫键、二硫键、空穴填充和单链连接,这些链接保证F-蛋白保持三聚体刺突状态。
具体实施方式
下面通过实施例并结合附图对本发明进一步说明。
实施例1:将SEQ AAL49410.1进行如下改造得到本发明的一种牛呼吸道胞合体病毒抗原蛋白:
牛呼吸道胞合体病毒F-蛋白氨基酸序列SEQ AAL49410.1第148位缬氨酸由半胱氨酸替代,第288位异亮氨酸由半胱氨酸替代,并由二硫键将两位点连接,将其进行相应的蛋白合成、表达、提纯,得到的牛呼吸道胞合体病毒抗原蛋白简称RD-BRSV-DB1,其氨基酸序列简称为SEQ DB1。
牛呼吸道胞合体病毒F-蛋白氨基酸序列SEQ AAL49410.1第158位亮氨酸由半胱氨酸替代,第290位异亮氨酸由半胱氨酸替代,并由二硫键将两位点连接,将其进行相应的蛋白合成、表达、提纯,得到的牛呼吸道胞合体病毒抗原蛋白简称RD-BRSV-DB2,其氨基酸序列简称为SEQ DB2。
牛呼吸道胞合体病毒F-蛋白氨基酸序列SEQ AAL49410.1第148位缬氨酸由半胱氨酸替代,第288位异亮氨酸由半胱氨酸替代,并由二硫键将两位点连接,同时将第260位点的亮氨酸由半胱氨酸替代,并在该位点实现空穴填充,将其进行相应的蛋白合成、表达、提纯,得到的牛呼吸道胞合体病毒抗原蛋白简称RD-BRSV-DB1-CF1,其氨基酸序列简称为SEQDB1-CF1。
牛呼吸道胞合体病毒F-蛋白氨基酸序列SEQ AAL49410.1第158位亮氨酸由半胱氨酸替代,第290位异亮氨酸由半胱氨酸替代,并由二硫键将两位点连接,同时将第260位点的亮氨酸由半胱氨酸替代,并在该位点实现空穴填充,将其进行相应的蛋白合成、表达、提纯,得到的牛呼吸道胞合体病毒抗原蛋白简称RD-BRSV-DB2-CF1,其氨基酸序列简称为SEQDB2-CF1。
牛呼吸道胞合体病毒F-蛋白氨基酸序列SEQ AAL49410.1第148位缬氨酸由半胱氨酸替代,第288位异亮氨酸由半胱氨酸替代,并由二硫键将两位点连接;同时将第260位点的亮氨酸由半胱氨酸替代,并在该位点实现空穴填充;剔除SEQ AAL49410.1序列中103至位点138位点的氨基酸序列,采用sgsgs连接102及139位点,将其进行相应的蛋白合成、表达、提纯,得到的牛呼吸道胞合体病毒抗原蛋白简称RD-BRSV-DB1-CF1-SC1,其氨基酸序列简称为SEQ DB1-CF1-SC1。
牛呼吸道胞合体病毒F-蛋白氨基酸序列SEQ AAL49410.1第158位亮氨酸由半胱氨酸替代,第290位异亮氨酸由半胱氨酸替代,并由二硫键将两位点连接,同时将第260位点的亮氨酸由半胱氨酸替代,并在该位点实现空穴填充;剔除SEQ AAL49410.1序列中103至位点138位点的氨基酸序列,采用sgsgs连接102及139位点,将其进行相应的蛋白合成、表达、提纯,得到的牛呼吸道胞合体病毒抗原蛋白简称RD-BRSV-DB2-CF1-SC1,其氨基酸序列简称为SEQ DB2-CF1-SC1。
牛呼吸道胞合体病毒F-蛋白氨基酸序列SEQ AAL49410.1第148位缬氨酸由半胱氨酸替代,第288位异亮氨酸由半胱氨酸替代,并由二硫键将两位点连接;同时将第260位点的亮氨酸由半胱氨酸替代,并在该位点实现空穴填充;剔除SEQ AAL49410.1序列中103至位点138位点的氨基酸序列,采用sgsgs连接102及139位点,第99位点天冬氨酸由半胱氨酸替代,第362位点丝氨酸由半胱氨酸替代,并在替代后的半胱氨酸之间连接内二硫键,进行相应的蛋白合成、表达、提纯,得到的牛呼吸道胞合体病毒抗原蛋白简称RD-BRSV-DB1-CF1-SC1-ID1,其氨基酸序列简称为SEQ DB1-CF1-SC1-ID1。
牛呼吸道胞合体病毒F-蛋白氨基酸序列SEQ AAL49410.1第148位缬氨酸由半胱氨酸替代,第288位异亮氨酸由半胱氨酸替代,并由二硫键将两位点连接;同时将第260位点的亮氨酸由半胱氨酸替代,并在该位点实现空穴填充;剔除SEQ AAL49410.1序列中103至位点142位点的氨基酸序列,采用sgsgs连接102及143位点,第99位点天冬氨酸由半胱氨酸替代,第362位点丝氨酸由半胱氨酸替代,并在替代后的半胱氨酸之间连接内二硫键,进行相应的蛋白合成、表达、提纯,得到的牛呼吸道胞合体病毒抗原蛋白简称RD-BRSV-DB1-CF1-SC2-ID1,其氨基酸序列简称为SEQ DB1-CF1-SC2-ID1。
牛呼吸道胞合体病毒F-蛋白氨基酸序列SEQ AAL49410.1第158位亮氨酸由半胱氨酸替代,第290位异亮氨酸由半胱氨酸替代,并由二硫键将两位点连接,同时将第260位点的亮氨酸由半胱氨酸替代,并在该位点实现空穴填充;剔除SEQ AAL49410.1序列中103至位点138位点的氨基酸序列,采用sgsgs连接102及139位点;第99位点天冬氨酸由半胱氨酸替代,第362位点丝氨酸由半胱氨酸替代,并在替代后的半胱氨酸之间连接内二硫键。其进行相应的蛋白合成、表达、提纯,得到的牛呼吸道胞合体病毒抗原蛋白简称RD-BRSV-DB2-CF1-SC1-ID1,其氨基酸序列简称为SEQ DB2-CF1-SC1-ID1。
牛呼吸道胞合体病毒F-蛋白氨基酸序列SEQ AAL49410.1第158位亮氨酸由半胱氨酸替代,第290位异亮氨酸由半胱氨酸替代,并由二硫键将两位点连接,同时将第260位点的亮氨酸由半胱氨酸替代,并在该位点实现空穴填充;剔除SEQ AAL49410.1序列中103至位点142位点的氨基酸序列,采用sgsgs连接102及143位点;第99位点天冬氨酸由半胱氨酸替代,第362位点丝氨酸由半胱氨酸替代,并在替代后的半胱氨酸之间连接内二硫键。其进行相应的蛋白合成、表达、提纯,得到的牛呼吸道胞合体病毒抗原蛋白简称RD-BRSV-DB2-CF1-SC2-ID1,其氨基酸序列简称为SEQ DB2-CF1-SC2-ID1。
免疫原性又称抗原性,指抗原刺激机体产生免疫应答能力的特性。免疫反应性指抗原分子能与相应免疫应答的产物(抗体或致敏淋巴细胞),在体内或体外发生特异性结合的性能,采用ELISA法对抗原与抗体的亲和力-免疫进行检验。ELISA法具有灵敏、特异、简单、快速、稳定及易于自动化操作等特点,作为免疫诊断中的一项新技术,已成功地应用于大分子抗原和小分子抗原的定量测定。高亲合力的抗体与抗原的结合力强,即抗原浓度很低时也有较多的抗体结合抗原形成免疫复合物。亲和性用平衡常数K来表示,K值越大,亲和性越高,与抗原结合也越牢固。表1给出了本发明制备的抗原蛋白分别在SiteØ、SiteQP、SiteⅤ、SiteⅡ位点与抗体结合的亲和性数据。
表1 实施例牛呼吸道胞合体病毒抗原蛋白的特性检测
本发明经过设计改造的F-蛋白具有较高的抗体库亲和性。经过改造后的抗原蛋白都保持融合前三聚体刺突状态(Trimer),且都能得到目的抗原蛋白。
本发明获得纯化的抗原蛋白与D25抗体进行特异性结合,经蛋白免疫电泳和ELISA方法检测,结果表明不仅具有较好的免疫原性,而且能够诱导小鼠产生较高的抗体水平,表2给出了D25抗体与本发明抗原蛋白特异性结合的免疫原性加权平均值,对照组为非变异野生种。
表2 实施例牛呼吸道胞合体病毒抗原蛋白与D25特异性结合的特性检测
抗原蛋白 | D25亲和力效价加权平均值 |
RD-BRSV-DB1 | 1449 |
RD-BRSV-DB2 | 653 |
RD-BRSV-DB1-CF1 | 2245 |
RD-BRSV-DB2-CF1 | 5643 |
RD-BRSV-DB1-CF1-SC1 | 2760 |
RD-BRSV-DB2-CF1-SC1 | 10445 |
RD-BRSV-DB1-CF1-SC1-ID1 | 6890 |
RD-BRSV-DB1-CF1-SC2-ID1 | 5381 |
RD-BRSV-DB2-CF1-SC1-ID1 | 3568 |
RD-BRSV-DB2-CF1-SC2-ID1 | 1258 |
非变异野生种 | 100 |
对本发明中的抗原蛋白进行物理化学稳定性进行测定,包括温度、pH、渗透压等方面,详细数据见表3,表中数据为在相应条件下的抗原蛋白活性与最佳抗原蛋白活性的比值,结果表明经过设计改造的抗原蛋白对温度、PH值、渗透压等呈现较好的稳定性,具有较高的反应活性。
表3实施例牛呼吸道胞合体病毒抗原蛋白的反应活性稳定性
实施例2:制备实施例1中RD-BRSV-DB1-CF1-SC1-ID1的具体工艺。看到蛋白机构和形状可以通过以下三种途径,分别为x-射线(x-ray Crystallography)、核磁共振(NMR)、电镜,本发明采用X-射线法对蛋白结构进行观察。采用Solution maker 600 plux系列将目标蛋白进行结晶,将结晶后的目标蛋白采用X-射线系统(SER-CAT22)收集结晶体数据,并使其成像,获得蛋白结构的电子云图,得到关键蛋白F-蛋白侵染前后的数据变化,侵染前后结构变化如图 2所示。
对上述电子云图进行云数据处理,利用相应的软件(Phenix)和野生蛋白序列进行数据模拟,形成蛋白结构的三维立体结构模拟图形。根据蛋白序列模拟出的三维蛋白结构图形得到F-蛋白的三聚体结构,详见图1。
按照晶体化学的原理,利用模拟软件进行抗原蛋白结构设计,其设计包括如图4所示的四种方式:内二硫键(intra disulphide bond)、二硫键(disulphide bond)、空穴填充(cavity filling)和单链连接(single chain),对野生种AAL49410.1进行设计。
将设计好的蛋白序列转译成DNA序列,采用invitrogen公司提供的Expi293F作为细胞载体在293Fectin培养基中进行培养5天,收集细胞培养液,将目标蛋白进行提纯精制得到设计好的纯化的BRSV F-蛋白,即RD-BRSV-DB1-CF1-SC1-ID1,改造后的牛呼吸道胞合体蛋白抗原侵染牛体后呈现稳定的融合前三聚体刺突状态见图3(左)。
上述具体实施方式仅是本发明的具体个案,本发明的专利保护范围包括但不限于上述具体实施方式的产品形态和式样,任何符合本发明权利要求书的一种牛呼吸道胞合体病毒抗原蛋白且任何所属技术领域的普通技术人员对其所做的适当变化或修饰,皆应落入本发明的专利保护范围。
SEQUENCE LISTING
<110> 烟台偌帝生物工程有限公司
<120> 一种牛呼吸道胞合体病毒抗原蛋白
<130>
<160> 11
<170> PatentIn version 3.3
<210> 1
<211> 569
<212> PRT
<213> 牛呼吸道胞合体病毒F-蛋白野生种
<400> 1
Met Arg Met Ile Ile Ser Ile Ile Leu Ile Ser Thr Tyr Val Pro His
1 5 10 15
Ile Thr Leu Cys Gln Asn Ile Thr Glu Glu Phe Tyr Gln Ser Thr Cys
20 25 30
Ser Ala Val Ser Arg Gly Tyr Leu Ser Ala Leu Arg Thr Gly Trp Tyr
35 40 45
Thr Ser Val Val Thr Ile Glu Leu Ser Lys Ile Gln Lys Asn Val Cys
50 55 60
Asn Gly Thr Asp Ser Lys Val Lys Leu Ile Lys Gln Glu Leu Glu Arg
65 70 75 80
Tyr Asn Asn Ala Val Val Glu Leu Gln Ser Leu Met Gln Asn Glu Pro
85 90 95
Thr Ser Ser Ser Arg Ala Lys Arg Gly Ile Pro Glu Ser Ile His Tyr
100 105 110
Thr Arg Asn Ser Thr Lys Lys Phe Tyr Gly Leu Met Gly Lys Lys Arg
115 120 125
Lys Arg Arg Phe Leu Gly Phe Leu Leu Gly Ile Gly Ser Ala Ile Ala
130 135 140
Ser Gly Val Ala Val Ser Lys Val Leu His Leu Glu Gly Glu Val Asn
145 150 155 160
Lys Ile Lys Asn Ala Leu Leu Ser Thr Asn Lys Ala Val Val Ser Leu
165 170 175
Ser Asn Gly Val Ser Val Leu Thr Ser Lys Val Leu Asp Leu Lys Asn
180 185 190
Tyr Ile Asp Lys Glu Leu Leu Pro Lys Val Asn Asn His Asp Cys Arg
195 200 205
Ile Ser Asn Ile Ala Thr Val Ile Glu Phe Gln Gln Lys Asn Asn Arg
210 215 220
Leu Leu Glu Ile Ala Arg Glu Phe Ser Val Asn Ala Gly Ile Thr Thr
225 230 235 240
Pro Leu Ser Thr Tyr Met Leu Thr Asn Ser Glu Leu Leu Ser Ile Ile
245 250 255
Asn Asp Met Pro Ile Thr Asn Asp Gln Lys Lys Leu Met Ser Ser Asn
260 265 270
Val Gln Ile Val Arg Gln Gln Ser Tyr Ser Ile Met Ser Val Val Lys
275 280 285
Glu Glu Val Ile Ala Tyr Val Val Gln Leu Pro Leu Tyr Gly Val Ile
290 295 300
Asp Thr Pro Cys Trp Lys Leu His Thr Ser Pro Leu Cys Thr Thr Asp
305 310 315 320
Asn Glu Glu Gly Ser Asn Ile Cys Leu Thr Arg Thr Asp Arg Gly Trp
325 330 335
Tyr Cys Asp Asn Ala Gly Ser Val Ser Phe Phe Pro Gln Ala Glu Thr
340 345 350
Cys Lys Val Gln Ser Asn Arg Val Phe Cys Asp Thr Met Asn Ser Leu
355 360 365
Thr Leu Pro Thr Asp Val Asn Leu Cys Asn Thr Asp Ile Phe Asn Ala
370 375 380
Lys Tyr Asp Cys Lys Ile Met Thr Ser Lys Thr Asp Ile Ser Ser Ser
385 390 395 400
Val Ile Thr Ser Ile Gly Ala Ile Val Ser Cys Tyr Gly Lys Thr Lys
405 410 415
Cys Thr Ala Ser Asn Lys Asn Arg Gly Ile Ile Lys Thr Phe Ser Asn
420 425 430
Gly Cys Asp Tyr Val Ser Asn Lys Gly Val Asp Thr Val Ser Val Gly
435 440 445
Asn Thr Leu Tyr Tyr Val Asn Lys Leu Glu Gly Lys Ala Leu Tyr Ile
450 455 460
Lys Gly Glu Pro Ile Ile Asn Tyr Tyr Asn Pro Leu Val Phe Pro Ser
465 470 475 480
Asp Glu Phe Asp Ala Ser Ile Ala Gln Val Asn Ala Lys Ile Asn Gln
485 490 495
Ser Leu Ala Phe Ile Arg Arg Ser Asp Glu Leu Leu His Ser Val Asp
500 505 510
Val Gly Lys Ser Thr Thr Asn Val Val Ile Thr Thr Ile Ile Ile Val
515 520 525
Ile Val Val Val Ile Leu Met Leu Ile Thr Val Gly Leu Leu Phe Tyr
530 535 540
Cys Lys Thr Arg Ser Thr Pro Ile Met Leu Gly Lys Asp Gln Leu Ser
545 550 555 560
Ser Ile Asn Asn Leu Ser Phe Ser Lys
565
<210> 2
<211> 489
<212> PRT
<213> 人工序列
<400> 2
Gln Asn Ile Thr Glu Glu Phe Tyr Gln Ser Thr Cys Ser Ala Val Ser
1 5 10 15
Arg Gly Tyr Leu Ser Ala Leu Arg Thr Gly Trp Tyr Thr Ser Val Val
20 25 30
Thr Ile Glu Leu Ser Lys Ile Gln Lys Asn Val Cys Asn Gly Thr Asp
35 40 45
Ser Lys Val Lys Leu Ile Lys Gln Glu Leu Glu Arg Tyr Asn Asn Ala
50 55 60
Val Val Glu Leu Gln Ser Leu Met Gln Asn Glu Pro Thr Ser Ser Ser
65 70 75 80
Arg Ala Lys Arg Gly Ile Pro Glu Ser Ile His Tyr Thr Arg Asn Ser
85 90 95
Thr Lys Lys Phe Tyr Gly Leu Met Gly Lys Lys Arg Lys Arg Arg Phe
100 105 110
Leu Gly Phe Leu Leu Gly Ile Gly Ser Ala Cys Ala Ser Gly Val Ala
115 120 125
Val Ser Lys Val Leu His Leu Glu Gly Glu Val Asn Lys Ile Lys Asn
130 135 140
Ala Leu Leu Ser Thr Asn Lys Ala Val Val Ser Leu Ser Asn Gly Val
145 150 155 160
Ser Val Leu Thr Ser Lys Val Leu Asp Leu Lys Asn Tyr Ile Asp Lys
165 170 175
Glu Leu Leu Pro Lys Val Asn Asn His Asp Cys Arg Ile Ser Asn Ile
180 185 190
Ala Thr Val Ile Glu Phe Gln Gln Lys Asn Asn Arg Leu Leu Glu Ile
195 200 205
Ala Arg Glu Phe Ser Val Asn Ala Gly Ile Thr Thr Pro Leu Ser Thr
210 215 220
Tyr Met Leu Thr Asn Ser Glu Leu Leu Ser Ile Ile Asn Asp Met Pro
225 230 235 240
Ile Thr Asn Asp Gln Lys Lys Leu Met Ser Ser Asn Val Gln Ile Val
245 250 255
Arg Gln Gln Ser Tyr Ser Cys Met Ser Val Val Lys Glu Glu Val Ile
260 265 270
Ala Tyr Val Val Gln Leu Pro Leu Tyr Gly Val Ile Asp Thr Pro Cys
275 280 285
Trp Lys Leu His Thr Ser Pro Leu Cys Thr Thr Asp Asn Glu Glu Gly
290 295 300
Ser Asn Ile Cys Leu Thr Arg Thr Asp Arg Gly Trp Tyr Cys Asp Asn
305 310 315 320
Ala Gly Ser Val Ser Phe Phe Pro Gln Ala Glu Thr Cys Lys Val Gln
325 330 335
Ser Asn Arg Val Phe Cys Asp Thr Met Asn Ser Leu Thr Leu Pro Thr
340 345 350
Asp Val Asn Leu Cys Asn Thr Asp Ile Phe Asn Ala Lys Tyr Asp Cys
355 360 365
Lys Ile Met Thr Ser Lys Thr Asp Ile Ser Ser Ser Val Ile Thr Ser
370 375 380
Ile Gly Ala Ile Val Ser Cys Tyr Gly Lys Thr Lys Cys Thr Ala Ser
385 390 395 400
Asn Lys Asn Arg Gly Ile Ile Lys Thr Phe Ser Asn Gly Cys Asp Tyr
405 410 415
Val Ser Asn Lys Gly Val Asp Thr Val Ser Val Gly Asn Thr Leu Tyr
420 425 430
Tyr Val Asn Lys Leu Glu Gly Lys Ala Leu Tyr Ile Lys Gly Glu Pro
435 440 445
Ile Ile Asn Tyr Tyr Asn Pro Leu Val Phe Pro Ser Asp Glu Phe Asp
450 455 460
Ala Ser Ile Ala Gln Val Asn Ala Lys Ile Asn Gln Ser Leu Ala Phe
465 470 475 480
Ile Arg Arg Ser Asp Glu Leu Leu His
485
<210> 3
<211> 489
<212> PRT
<213> 人工序列
<400> 3
Gln Asn Ile Thr Glu Glu Phe Tyr Gln Ser Thr Cys Ser Ala Val Ser
1 5 10 15
Arg Gly Tyr Leu Ser Ala Leu Arg Thr Gly Trp Tyr Thr Ser Val Val
20 25 30
Thr Ile Glu Leu Ser Lys Ile Gln Lys Asn Val Cys Asn Gly Thr Asp
35 40 45
Ser Lys Val Lys Leu Ile Lys Gln Glu Leu Glu Arg Tyr Asn Asn Ala
50 55 60
Val Val Glu Leu Gln Ser Leu Met Gln Asn Glu Pro Thr Ser Ser Ser
65 70 75 80
Arg Ala Lys Arg Gly Ile Pro Glu Ser Ile His Tyr Thr Arg Asn Ser
85 90 95
Thr Lys Lys Phe Tyr Gly Leu Met Gly Lys Lys Arg Lys Arg Arg Phe
100 105 110
Leu Gly Phe Leu Leu Gly Ile Gly Ser Ala Ile Ala Ser Gly Val Ala
115 120 125
Val Ser Lys Val Cys His Leu Glu Gly Glu Val Asn Lys Ile Lys Asn
130 135 140
Ala Leu Leu Ser Thr Asn Lys Ala Val Val Ser Leu Ser Asn Gly Val
145 150 155 160
Ser Val Leu Thr Ser Lys Val Leu Asp Leu Lys Asn Tyr Ile Asp Lys
165 170 175
Glu Leu Leu Pro Lys Val Asn Asn His Asp Cys Arg Ile Ser Asn Ile
180 185 190
Ala Thr Val Ile Glu Phe Gln Gln Lys Asn Asn Arg Leu Leu Glu Ile
195 200 205
Ala Arg Glu Phe Ser Val Asn Ala Gly Ile Thr Thr Pro Leu Ser Thr
210 215 220
Tyr Met Leu Thr Asn Ser Glu Leu Leu Ser Ile Ile Asn Asp Met Pro
225 230 235 240
Ile Thr Asn Asp Gln Lys Lys Leu Met Ser Ser Asn Val Gln Ile Val
245 250 255
Arg Gln Gln Ser Tyr Ser Ile Met Cys Val Val Lys Glu Glu Val Ile
260 265 270
Ala Tyr Val Val Gln Leu Pro Leu Tyr Gly Val Ile Asp Thr Pro Cys
275 280 285
Trp Lys Leu His Thr Ser Pro Leu Cys Thr Thr Asp Asn Glu Glu Gly
290 295 300
Ser Asn Ile Cys Leu Thr Arg Thr Asp Arg Gly Trp Tyr Cys Asp Asn
305 310 315 320
Ala Gly Ser Val Ser Phe Phe Pro Gln Ala Glu Thr Cys Lys Val Gln
325 330 335
Ser Asn Arg Val Phe Cys Asp Thr Met Asn Ser Leu Thr Leu Pro Thr
340 345 350
Asp Val Asn Leu Cys Asn Thr Asp Ile Phe Asn Ala Lys Tyr Asp Cys
355 360 365
Lys Ile Met Thr Ser Lys Thr Asp Ile Ser Ser Ser Val Ile Thr Ser
370 375 380
Ile Gly Ala Ile Val Ser Cys Tyr Gly Lys Thr Lys Cys Thr Ala Ser
385 390 395 400
Asn Lys Asn Arg Gly Ile Ile Lys Thr Phe Ser Asn Gly Cys Asp Tyr
405 410 415
Val Ser Asn Lys Gly Val Asp Thr Val Ser Val Gly Asn Thr Leu Tyr
420 425 430
Tyr Val Asn Lys Leu Glu Gly Lys Ala Leu Tyr Ile Lys Gly Glu Pro
435 440 445
Ile Ile Asn Tyr Tyr Asn Pro Leu Val Phe Pro Ser Asp Glu Phe Asp
450 455 460
Ala Ser Ile Ala Gln Val Asn Ala Lys Ile Asn Gln Ser Leu Ala Phe
465 470 475 480
Ile Arg Arg Ser Asp Glu Leu Leu His
485
<210> 4
<211> 489
<212> PRT
<213> 人工序列
<400> 4
Gln Asn Ile Thr Glu Glu Phe Tyr Gln Ser Thr Cys Ser Ala Val Ser
1 5 10 15
Arg Gly Tyr Leu Ser Ala Leu Arg Thr Gly Trp Tyr Thr Ser Val Val
20 25 30
Thr Ile Glu Leu Ser Lys Ile Gln Lys Asn Val Cys Asn Gly Thr Asp
35 40 45
Ser Lys Val Lys Leu Ile Lys Gln Glu Leu Glu Arg Tyr Asn Asn Ala
50 55 60
Val Val Glu Leu Gln Ser Leu Met Gln Asn Glu Pro Thr Ser Ser Ser
65 70 75 80
Arg Ala Lys Arg Gly Ile Pro Glu Ser Ile His Tyr Thr Arg Asn Ser
85 90 95
Thr Lys Lys Phe Tyr Gly Leu Met Gly Lys Lys Arg Lys Arg Arg Phe
100 105 110
Leu Gly Phe Leu Leu Gly Ile Gly Ser Ala Cys Ala Ser Gly Val Ala
115 120 125
Val Ser Lys Val Leu His Leu Glu Gly Glu Val Asn Lys Ile Lys Asn
130 135 140
Ala Leu Leu Ser Thr Asn Lys Ala Val Val Ser Leu Ser Asn Gly Val
145 150 155 160
Ser Val Leu Thr Ser Lys Val Leu Asp Leu Lys Asn Tyr Ile Asp Lys
165 170 175
Glu Leu Leu Pro Lys Val Asn Asn His Asp Cys Arg Ile Ser Asn Ile
180 185 190
Ala Thr Val Ile Glu Phe Gln Gln Lys Asn Asn Arg Leu Leu Glu Ile
195 200 205
Ala Arg Glu Phe Ser Val Asn Ala Gly Ile Thr Thr Pro Leu Ser Thr
210 215 220
Tyr Met Leu Thr Asn Ser Glu Leu Leu Ser Phe Ile Asn Asp Met Pro
225 230 235 240
Ile Thr Asn Asp Gln Lys Lys Leu Met Ser Ser Asn Val Gln Ile Val
245 250 255
Arg Gln Gln Ser Tyr Ser Cys Met Ser Val Val Lys Glu Glu Val Ile
260 265 270
Ala Tyr Val Val Gln Leu Pro Leu Tyr Gly Val Ile Asp Thr Pro Cys
275 280 285
Trp Lys Leu His Thr Ser Pro Leu Cys Thr Thr Asp Asn Glu Glu Gly
290 295 300
Ser Asn Ile Cys Leu Thr Arg Thr Asp Arg Gly Trp Tyr Cys Asp Asn
305 310 315 320
Ala Gly Ser Val Ser Phe Phe Pro Gln Ala Glu Thr Cys Lys Val Gln
325 330 335
Ser Asn Arg Val Phe Cys Asp Thr Met Asn Ser Leu Thr Leu Pro Thr
340 345 350
Asp Val Asn Leu Cys Asn Thr Asp Ile Phe Asn Ala Lys Tyr Asp Cys
355 360 365
Lys Ile Met Thr Ser Lys Thr Asp Ile Ser Ser Ser Val Ile Thr Ser
370 375 380
Ile Gly Ala Ile Val Ser Cys Tyr Gly Lys Thr Lys Cys Thr Ala Ser
385 390 395 400
Asn Lys Asn Arg Gly Ile Ile Lys Thr Phe Ser Asn Gly Cys Asp Tyr
405 410 415
Val Ser Asn Lys Gly Val Asp Thr Val Ser Val Gly Asn Thr Leu Tyr
420 425 430
Tyr Val Asn Lys Leu Glu Gly Lys Ala Leu Tyr Ile Lys Gly Glu Pro
435 440 445
Ile Ile Asn Tyr Tyr Asn Pro Leu Val Phe Pro Ser Asp Glu Phe Asp
450 455 460
Ala Ser Ile Ala Gln Val Asn Ala Lys Ile Asn Gln Ser Leu Ala Phe
465 470 475 480
Ile Arg Arg Ser Asp Glu Leu Leu His
485
<210> 5
<211> 489
<212> PRT
<213> 人工序列
<400> 5
Gln Asn Ile Thr Glu Glu Phe Tyr Gln Ser Thr Cys Ser Ala Val Ser
1 5 10 15
Arg Gly Tyr Leu Ser Ala Leu Arg Thr Gly Trp Tyr Thr Ser Val Val
20 25 30
Thr Ile Glu Leu Ser Lys Ile Gln Lys Asn Val Cys Asn Gly Thr Asp
35 40 45
Ser Lys Val Lys Leu Ile Lys Gln Glu Leu Glu Arg Tyr Asn Asn Ala
50 55 60
Val Val Glu Leu Gln Ser Leu Met Gln Asn Glu Pro Thr Ser Ser Ser
65 70 75 80
Arg Ala Lys Arg Gly Ile Pro Glu Ser Ile His Tyr Thr Arg Asn Ser
85 90 95
Thr Lys Lys Phe Tyr Gly Leu Met Gly Lys Lys Arg Lys Arg Arg Phe
100 105 110
Leu Gly Phe Leu Leu Gly Ile Gly Ser Ala Ile Ala Ser Gly Val Ala
115 120 125
Val Ser Lys Val Cys His Leu Glu Gly Glu Val Asn Lys Ile Lys Asn
130 135 140
Ala Leu Leu Ser Thr Asn Lys Ala Val Val Ser Leu Ser Asn Gly Val
145 150 155 160
Ser Val Leu Thr Ser Lys Val Leu Asp Leu Lys Asn Tyr Ile Asp Lys
165 170 175
Glu Leu Leu Pro Lys Val Asn Asn His Asp Cys Arg Ile Ser Asn Ile
180 185 190
Ala Thr Val Ile Glu Phe Gln Gln Lys Asn Asn Arg Leu Leu Glu Ile
195 200 205
Ala Arg Glu Phe Ser Val Asn Ala Gly Ile Thr Thr Pro Leu Ser Thr
210 215 220
Tyr Met Leu Thr Asn Ser Glu Leu Leu Ser Phe Ile Asn Asp Met Pro
225 230 235 240
Ile Thr Asn Asp Gln Lys Lys Leu Met Ser Ser Asn Val Gln Ile Val
245 250 255
Arg Gln Gln Ser Tyr Ser Ile Met Cys Val Val Lys Glu Glu Val Ile
260 265 270
Ala Tyr Val Val Gln Leu Pro Leu Tyr Gly Val Ile Asp Thr Pro Cys
275 280 285
Trp Lys Leu His Thr Ser Pro Leu Cys Thr Thr Asp Asn Glu Glu Gly
290 295 300
Ser Asn Ile Cys Leu Thr Arg Thr Asp Arg Gly Trp Tyr Cys Asp Asn
305 310 315 320
Ala Gly Ser Val Ser Phe Phe Pro Gln Ala Glu Thr Cys Lys Val Gln
325 330 335
Ser Asn Arg Val Phe Cys Asp Thr Met Asn Ser Leu Thr Leu Pro Thr
340 345 350
Asp Val Asn Leu Cys Asn Thr Asp Ile Phe Asn Ala Lys Tyr Asp Cys
355 360 365
Lys Ile Met Thr Ser Lys Thr Asp Ile Ser Ser Ser Val Ile Thr Ser
370 375 380
Ile Gly Ala Ile Val Ser Cys Tyr Gly Lys Thr Lys Cys Thr Ala Ser
385 390 395 400
Asn Lys Asn Arg Gly Ile Ile Lys Thr Phe Ser Asn Gly Cys Asp Tyr
405 410 415
Val Ser Asn Lys Gly Val Asp Thr Val Ser Val Gly Asn Thr Leu Tyr
420 425 430
Tyr Val Asn Lys Leu Glu Gly Lys Ala Leu Tyr Ile Lys Gly Glu Pro
435 440 445
Ile Ile Asn Tyr Tyr Asn Pro Leu Val Phe Pro Ser Asp Glu Phe Asp
450 455 460
Ala Ser Ile Ala Gln Val Asn Ala Lys Ile Asn Gln Ser Leu Ala Phe
465 470 475 480
Ile Arg Arg Ser Asp Glu Leu Leu His
485
<210> 6
<211> 454
<212> PRT
<213> 人工序列
<400> 6
Gln Asn Ile Thr Glu Glu Phe Tyr Gln Ser Thr Cys Ser Ala Val Ser
1 5 10 15
Arg Gly Tyr Leu Ser Ala Leu Arg Thr Gly Trp Tyr Thr Ser Val Val
20 25 30
Thr Ile Glu Leu Ser Lys Ile Gln Lys Asn Val Cys Asn Gly Thr Asp
35 40 45
Ser Lys Val Lys Leu Ile Lys Gln Glu Leu Glu Arg Tyr Asn Asn Ala
50 55 60
Val Val Glu Leu Gln Ser Leu Met Gln Asn Glu Pro Thr Ser Gly Ser
65 70 75 80
Gly Ser Gly Ile Gly Ser Ala Cys Ala Ser Gly Val Ala Val Ser Lys
85 90 95
Val Leu His Leu Glu Gly Glu Val Asn Lys Ile Lys Asn Ala Leu Leu
100 105 110
Ser Thr Asn Lys Ala Val Val Ser Leu Ser Asn Gly Val Ser Val Leu
115 120 125
Thr Ser Lys Val Leu Asp Leu Lys Asn Tyr Ile Asp Lys Glu Leu Leu
130 135 140
Pro Lys Val Asn Asn His Asp Cys Arg Ile Ser Asn Ile Ala Thr Val
145 150 155 160
Ile Glu Phe Gln Gln Lys Asn Asn Arg Leu Leu Glu Ile Ala Arg Glu
165 170 175
Phe Ser Val Asn Ala Gly Ile Thr Thr Pro Leu Ser Thr Tyr Met Leu
180 185 190
Thr Asn Ser Glu Leu Leu Ser Phe Ile Asn Asp Met Pro Ile Thr Asn
195 200 205
Asp Gln Lys Lys Leu Met Ser Ser Asn Val Gln Ile Val Arg Gln Gln
210 215 220
Ser Tyr Ser Cys Met Ser Val Val Lys Glu Glu Val Ile Ala Tyr Val
225 230 235 240
Val Gln Leu Pro Leu Tyr Gly Val Ile Asp Thr Pro Cys Trp Lys Leu
245 250 255
His Thr Ser Pro Leu Cys Thr Thr Asp Asn Glu Glu Gly Ser Asn Ile
260 265 270
Cys Leu Thr Arg Thr Asp Arg Gly Trp Tyr Cys Asp Asn Ala Gly Ser
275 280 285
Val Ser Phe Phe Pro Gln Ala Glu Thr Cys Lys Val Gln Ser Asn Arg
290 295 300
Val Phe Cys Asp Thr Met Asn Ser Leu Thr Leu Pro Thr Asp Val Asn
305 310 315 320
Leu Cys Asn Thr Asp Ile Phe Asn Ala Lys Tyr Asp Cys Lys Ile Met
325 330 335
Thr Ser Lys Thr Asp Ile Ser Ser Ser Val Ile Thr Ser Ile Gly Ala
340 345 350
Ile Val Ser Cys Tyr Gly Lys Thr Lys Cys Thr Ala Ser Asn Lys Asn
355 360 365
Arg Gly Ile Ile Lys Thr Phe Ser Asn Gly Cys Asp Tyr Val Ser Asn
370 375 380
Lys Gly Val Asp Thr Val Ser Val Gly Asn Thr Leu Tyr Tyr Val Asn
385 390 395 400
Lys Leu Glu Gly Lys Ala Leu Tyr Ile Lys Gly Glu Pro Ile Ile Asn
405 410 415
Tyr Tyr Asn Pro Leu Val Phe Pro Ser Asp Glu Phe Asp Ala Ser Ile
420 425 430
Ala Gln Val Asn Ala Lys Ile Asn Gln Ser Leu Ala Phe Ile Arg Arg
435 440 445
Ser Asp Glu Leu Leu His
450
<210> 7
<211> 454
<212> PRT
<213> 人工序列
<400> 7
Gln Asn Ile Thr Glu Glu Phe Tyr Gln Ser Thr Cys Ser Ala Val Ser
1 5 10 15
Arg Gly Tyr Leu Ser Ala Leu Arg Thr Gly Trp Tyr Thr Ser Val Val
20 25 30
Thr Ile Glu Leu Ser Lys Ile Gln Lys Asn Val Cys Asn Gly Thr Asp
35 40 45
Ser Lys Val Lys Leu Ile Lys Gln Glu Leu Glu Arg Tyr Asn Asn Ala
50 55 60
Val Val Glu Leu Gln Ser Leu Met Gln Asn Glu Pro Thr Ser Gly Ser
65 70 75 80
Gly Ser Gly Ile Gly Ser Ala Ile Ala Ser Gly Val Ala Val Ser Lys
85 90 95
Val Cys His Leu Glu Gly Glu Val Asn Lys Ile Lys Asn Ala Leu Leu
100 105 110
Ser Thr Asn Lys Ala Val Val Ser Leu Ser Asn Gly Val Ser Val Leu
115 120 125
Thr Ser Lys Val Leu Asp Leu Lys Asn Tyr Ile Asp Lys Glu Leu Leu
130 135 140
Pro Lys Val Asn Asn His Asp Cys Arg Ile Ser Asn Ile Ala Thr Val
145 150 155 160
Ile Glu Phe Gln Gln Lys Asn Asn Arg Leu Leu Glu Ile Ala Arg Glu
165 170 175
Phe Ser Val Asn Ala Gly Ile Thr Thr Pro Leu Ser Thr Tyr Met Leu
180 185 190
Thr Asn Ser Glu Leu Leu Ser Phe Ile Asn Asp Met Pro Ile Thr Asn
195 200 205
Asp Gln Lys Lys Leu Met Ser Ser Asn Val Gln Ile Val Arg Gln Gln
210 215 220
Ser Tyr Ser Ile Met Cys Val Val Lys Glu Glu Val Ile Ala Tyr Val
225 230 235 240
Val Gln Leu Pro Leu Tyr Gly Val Ile Asp Thr Pro Cys Trp Lys Leu
245 250 255
His Thr Ser Pro Leu Cys Thr Thr Asp Asn Glu Glu Gly Ser Asn Ile
260 265 270
Cys Leu Thr Arg Thr Asp Arg Gly Trp Tyr Cys Asp Asn Ala Gly Ser
275 280 285
Val Ser Phe Phe Pro Gln Ala Glu Thr Cys Lys Val Gln Ser Asn Arg
290 295 300
Val Phe Cys Asp Thr Met Asn Ser Leu Thr Leu Pro Thr Asp Val Asn
305 310 315 320
Leu Cys Asn Thr Asp Ile Phe Asn Ala Lys Tyr Asp Cys Lys Ile Met
325 330 335
Thr Ser Lys Thr Asp Ile Ser Ser Ser Val Ile Thr Ser Ile Gly Ala
340 345 350
Ile Val Ser Cys Tyr Gly Lys Thr Lys Cys Thr Ala Ser Asn Lys Asn
355 360 365
Arg Gly Ile Ile Lys Thr Phe Ser Asn Gly Cys Asp Tyr Val Ser Asn
370 375 380
Lys Gly Val Asp Thr Val Ser Val Gly Asn Thr Leu Tyr Tyr Val Asn
385 390 395 400
Lys Leu Glu Gly Lys Ala Leu Tyr Ile Lys Gly Glu Pro Ile Ile Asn
405 410 415
Tyr Tyr Asn Pro Leu Val Phe Pro Ser Asp Glu Phe Asp Ala Ser Ile
420 425 430
Ala Gln Val Asn Ala Lys Ile Asn Gln Ser Leu Ala Phe Ile Arg Arg
435 440 445
Ser Asp Glu Leu Leu His
450
<210> 8
<211> 454
<212> PRT
<213> 人工序列
<400> 8
Gln Asn Ile Thr Glu Glu Phe Tyr Gln Ser Thr Cys Ser Ala Val Ser
1 5 10 15
Arg Gly Tyr Leu Ser Ala Leu Arg Thr Gly Trp Tyr Thr Ser Val Val
20 25 30
Thr Ile Glu Leu Ser Lys Ile Gln Lys Asn Val Cys Asn Gly Thr Asp
35 40 45
Ser Lys Val Lys Leu Ile Lys Gln Glu Leu Glu Arg Tyr Asn Asn Ala
50 55 60
Val Val Glu Leu Gln Ser Leu Met Gln Cys Glu Pro Thr Ser Gly Ser
65 70 75 80
Gly Ser Gly Ile Gly Ser Ala Cys Ala Ser Gly Val Ala Val Ser Lys
85 90 95
Val Leu His Leu Glu Gly Glu Val Asn Lys Ile Lys Asn Ala Leu Leu
100 105 110
Ser Thr Asn Lys Ala Val Val Ser Leu Ser Asn Gly Val Ser Val Leu
115 120 125
Thr Ser Lys Val Leu Asp Leu Lys Asn Tyr Ile Asp Lys Glu Leu Leu
130 135 140
Pro Lys Val Asn Asn His Asp Cys Arg Ile Ser Asn Ile Ala Thr Val
145 150 155 160
Ile Glu Phe Gln Gln Lys Asn Asn Arg Leu Leu Glu Ile Ala Arg Glu
165 170 175
Phe Ser Val Asn Ala Gly Ile Thr Thr Pro Leu Ser Thr Tyr Met Leu
180 185 190
Thr Asn Ser Glu Leu Leu Ser Phe Ile Asn Asp Met Pro Ile Thr Asn
195 200 205
Asp Gln Lys Lys Leu Met Ser Ser Asn Val Gln Ile Val Arg Gln Gln
210 215 220
Ser Tyr Ser Cys Met Ser Val Val Lys Glu Glu Val Ile Ala Tyr Val
225 230 235 240
Val Gln Leu Pro Leu Tyr Gly Val Ile Asp Thr Pro Cys Trp Lys Leu
245 250 255
His Thr Ser Pro Leu Cys Thr Thr Asp Asn Glu Glu Gly Ser Asn Ile
260 265 270
Cys Leu Thr Arg Thr Asp Arg Gly Trp Tyr Cys Asp Asn Ala Gly Ser
275 280 285
Val Ser Phe Phe Pro Gln Ala Glu Thr Cys Lys Val Gln Cys Asn Arg
290 295 300
Val Phe Cys Asp Thr Met Asn Ser Leu Thr Leu Pro Thr Asp Val Asn
305 310 315 320
Leu Cys Asn Thr Asp Ile Phe Asn Ala Lys Tyr Asp Cys Lys Ile Met
325 330 335
Thr Ser Lys Thr Asp Ile Ser Ser Ser Val Ile Thr Ser Ile Gly Ala
340 345 350
Ile Val Ser Cys Tyr Gly Lys Thr Lys Cys Thr Ala Ser Asn Lys Asn
355 360 365
Arg Gly Ile Ile Lys Thr Phe Ser Asn Gly Cys Asp Tyr Val Ser Asn
370 375 380
Lys Gly Val Asp Thr Val Ser Val Gly Asn Thr Leu Tyr Tyr Val Asn
385 390 395 400
Lys Leu Glu Gly Lys Ala Leu Tyr Ile Lys Gly Glu Pro Ile Ile Asn
405 410 415
Tyr Tyr Asn Pro Leu Val Phe Pro Ser Asp Glu Phe Asp Ala Ser Ile
420 425 430
Ala Gln Val Asn Ala Lys Ile Asn Gln Ser Leu Ala Phe Ile Arg Arg
435 440 445
Ser Asp Glu Leu Leu His
450
<210> 9
<211> 454
<212> PRT
<213> 人工序列
<400> 9
Gln Asn Ile Thr Glu Glu Phe Tyr Gln Ser Thr Cys Ser Ala Val Ser
1 5 10 15
Arg Gly Tyr Leu Ser Ala Leu Arg Thr Gly Trp Tyr Thr Ser Val Val
20 25 30
Thr Ile Glu Leu Ser Lys Ile Gln Lys Asn Val Cys Asn Gly Thr Asp
35 40 45
Ser Lys Val Lys Leu Ile Lys Gln Glu Leu Glu Arg Tyr Asn Asn Ala
50 55 60
Val Val Glu Leu Gln Ser Leu Met Gln Cys Glu Pro Thr Ser Gly Ser
65 70 75 80
Gly Ser Gly Ile Gly Ser Ala Ile Ala Ser Gly Val Ala Val Ser Lys
85 90 95
Val Cys His Leu Glu Gly Glu Val Asn Lys Ile Lys Asn Ala Leu Leu
100 105 110
Ser Thr Asn Lys Ala Val Val Ser Leu Ser Asn Gly Val Ser Val Leu
115 120 125
Thr Ser Lys Val Leu Asp Leu Lys Asn Tyr Ile Asp Lys Glu Leu Leu
130 135 140
Pro Lys Val Asn Asn His Asp Cys Arg Ile Ser Asn Ile Ala Thr Val
145 150 155 160
Ile Glu Phe Gln Gln Lys Asn Asn Arg Leu Leu Glu Ile Ala Arg Glu
165 170 175
Phe Ser Val Asn Ala Gly Ile Thr Thr Pro Leu Ser Thr Tyr Met Leu
180 185 190
Thr Asn Ser Glu Leu Leu Ser Phe Ile Asn Asp Met Pro Ile Thr Asn
195 200 205
Asp Gln Lys Lys Leu Met Ser Ser Asn Val Gln Ile Val Arg Gln Gln
210 215 220
Ser Tyr Ser Ile Met Cys Val Val Lys Glu Glu Val Ile Ala Tyr Val
225 230 235 240
Val Gln Leu Pro Leu Tyr Gly Val Ile Asp Thr Pro Cys Trp Lys Leu
245 250 255
His Thr Ser Pro Leu Cys Thr Thr Asp Asn Glu Glu Gly Ser Asn Ile
260 265 270
Cys Leu Thr Arg Thr Asp Arg Gly Trp Tyr Cys Asp Asn Ala Gly Ser
275 280 285
Val Ser Phe Phe Pro Gln Ala Glu Thr Cys Lys Val Gln Cys Asn Arg
290 295 300
Val Phe Cys Asp Thr Met Asn Ser Leu Thr Leu Pro Thr Asp Val Asn
305 310 315 320
Leu Cys Asn Thr Asp Ile Phe Asn Ala Lys Tyr Asp Cys Lys Ile Met
325 330 335
Thr Ser Lys Thr Asp Ile Ser Ser Ser Val Ile Thr Ser Ile Gly Ala
340 345 350
Ile Val Ser Cys Tyr Gly Lys Thr Lys Cys Thr Ala Ser Asn Lys Asn
355 360 365
Arg Gly Ile Ile Lys Thr Phe Ser Asn Gly Cys Asp Tyr Val Ser Asn
370 375 380
Lys Gly Val Asp Thr Val Ser Val Gly Asn Thr Leu Tyr Tyr Val Asn
385 390 395 400
Lys Leu Glu Gly Lys Ala Leu Tyr Ile Lys Gly Glu Pro Ile Ile Asn
405 410 415
Tyr Tyr Asn Pro Leu Val Phe Pro Ser Asp Glu Phe Asp Ala Ser Ile
420 425 430
Ala Gln Val Asn Ala Lys Ile Asn Gln Ser Leu Ala Phe Ile Arg Arg
435 440 445
Ser Asp Glu Leu Leu His
450
<210> 10
<211> 454
<212> PRT
<213> 人工序列
<400> 10
Gln Asn Ile Thr Glu Glu Phe Tyr Gln Ser Thr Cys Ser Ala Val Ser
1 5 10 15
Arg Gly Tyr Leu Ser Ala Leu Arg Thr Gly Trp Tyr Thr Ser Val Val
20 25 30
Thr Ile Glu Leu Ser Lys Ile Gln Lys Asn Val Cys Asn Gly Thr Asp
35 40 45
Ser Lys Val Lys Leu Ile Lys Gln Glu Leu Glu Arg Tyr Asn Asn Ala
50 55 60
Val Val Glu Leu Gln Ser Leu Met Gln Cys Glu Pro Thr Ser Gly Ser
65 70 75 80
Gly Ser Gly Ile Gly Ser Ala Cys Ala Ser Gly Val Ala Val Ser Lys
85 90 95
Val Leu His Leu Glu Gly Glu Val Asn Lys Ile Lys Asn Ala Leu Leu
100 105 110
Ser Thr Asn Lys Ala Val Val Ser Leu Ser Asn Gly Val Ser Val Leu
115 120 125
Thr Ser Lys Val Leu Asp Leu Lys Asn Tyr Ile Asp Lys Glu Leu Leu
130 135 140
Pro Lys Val Asn Asn His Asp Cys Arg Ile Ser Asn Ile Ala Thr Val
145 150 155 160
Ile Glu Phe Gln Gln Lys Asn Asn Arg Leu Leu Glu Ile Ala Arg Glu
165 170 175
Phe Ser Val Asn Ala Gly Ile Thr Thr Pro Leu Ser Thr Tyr Met Leu
180 185 190
Thr Asn Ser Glu Leu Leu Ser Phe Ile Asn Asp Met Pro Ile Thr Asn
195 200 205
Asp Gln Lys Lys Leu Met Ser Ser Asn Val Gln Ile Val Arg Gln Gln
210 215 220
Ser Tyr Ser Cys Met Ser Val Val Lys Glu Glu Val Ile Ala Tyr Val
225 230 235 240
Val Gln Leu Pro Leu Tyr Gly Val Ile Asp Thr Pro Cys Trp Lys Leu
245 250 255
His Thr Ser Pro Leu Cys Thr Thr Asp Asn Glu Glu Gly Ser Asn Ile
260 265 270
Cys Leu Thr Arg Thr Asp Arg Gly Trp Tyr Cys Asp Asn Ala Gly Ser
275 280 285
Val Ser Phe Phe Pro Gln Ala Glu Thr Cys Lys Val Gln Cys Asn Arg
290 295 300
Val Phe Cys Asp Thr Met Asn Ser Leu Thr Leu Pro Thr Asp Val Asn
305 310 315 320
Leu Cys Asn Thr Asp Ile Phe Asn Ala Lys Tyr Asp Cys Lys Ile Met
325 330 335
Thr Ser Lys Thr Asp Ile Ser Ser Ser Val Ile Thr Ser Ile Gly Ala
340 345 350
Ile Val Ser Cys Tyr Gly Lys Thr Lys Cys Thr Ala Ser Asn Lys Asn
355 360 365
Arg Gly Ile Ile Lys Thr Phe Ser Asn Gly Cys Asp Tyr Val Ser Asn
370 375 380
Lys Gly Val Asp Thr Val Ser Val Gly Asn Thr Leu Tyr Tyr Val Asn
385 390 395 400
Lys Leu Glu Gly Lys Ala Leu Tyr Ile Lys Gly Glu Pro Ile Ile Asn
405 410 415
Tyr Tyr Asn Pro Leu Val Phe Pro Ser Asp Glu Phe Asp Ala Ser Ile
420 425 430
Ala Gln Val Asn Ala Lys Ile Asn Gln Ser Leu Ala Phe Ile Arg Arg
435 440 445
Ser Asp Glu Leu Leu His
450
<210> 11
<211> 454
<212> PRT
<213> 人工序列
<400> 11
Gln Asn Ile Thr Glu Glu Phe Tyr Gln Ser Thr Cys Ser Ala Val Ser
1 5 10 15
Arg Gly Tyr Leu Ser Ala Leu Arg Thr Gly Trp Tyr Thr Ser Val Val
20 25 30
Thr Ile Glu Leu Ser Lys Ile Gln Lys Asn Val Cys Asn Gly Thr Asp
35 40 45
Ser Lys Val Lys Leu Ile Lys Gln Glu Leu Glu Arg Tyr Asn Asn Ala
50 55 60
Val Val Glu Leu Gln Ser Leu Met Gln Cys Glu Pro Thr Ser Gly Ser
65 70 75 80
Gly Ser Gly Ile Gly Ser Ala Ile Ala Ser Gly Val Ala Val Ser Lys
85 90 95
Val Cys His Leu Glu Gly Glu Val Asn Lys Ile Lys Asn Ala Leu Leu
100 105 110
Ser Thr Asn Lys Ala Val Val Ser Leu Ser Asn Gly Val Ser Val Leu
115 120 125
Thr Ser Lys Val Leu Asp Leu Lys Asn Tyr Ile Asp Lys Glu Leu Leu
130 135 140
Pro Lys Val Asn Asn His Asp Cys Arg Ile Ser Asn Ile Ala Thr Val
145 150 155 160
Ile Glu Phe Gln Gln Lys Asn Asn Arg Leu Leu Glu Ile Ala Arg Glu
165 170 175
Phe Ser Val Asn Ala Gly Ile Thr Thr Pro Leu Ser Thr Tyr Met Leu
180 185 190
Thr Asn Ser Glu Leu Leu Ser Phe Ile Asn Asp Met Pro Ile Thr Asn
195 200 205
Asp Gln Lys Lys Leu Met Ser Ser Asn Val Gln Ile Val Arg Gln Gln
210 215 220
Ser Tyr Ser Ile Met Cys Val Val Lys Glu Glu Val Ile Ala Tyr Val
225 230 235 240
Val Gln Leu Pro Leu Tyr Gly Val Ile Asp Thr Pro Cys Trp Lys Leu
245 250 255
His Thr Ser Pro Leu Cys Thr Thr Asp Asn Glu Glu Gly Ser Asn Ile
260 265 270
Cys Leu Thr Arg Thr Asp Arg Gly Trp Tyr Cys Asp Asn Ala Gly Ser
275 280 285
Val Ser Phe Phe Pro Gln Ala Glu Thr Cys Lys Val Gln Cys Asn Arg
290 295 300
Val Phe Cys Asp Thr Met Asn Ser Leu Thr Leu Pro Thr Asp Val Asn
305 310 315 320
Leu Cys Asn Thr Asp Ile Phe Asn Ala Lys Tyr Asp Cys Lys Ile Met
325 330 335
Thr Ser Lys Thr Asp Ile Ser Ser Ser Val Ile Thr Ser Ile Gly Ala
340 345 350
Ile Val Ser Cys Tyr Gly Lys Thr Lys Cys Thr Ala Ser Asn Lys Asn
355 360 365
Arg Gly Ile Ile Lys Thr Phe Ser Asn Gly Cys Asp Tyr Val Ser Asn
370 375 380
Lys Gly Val Asp Thr Val Ser Val Gly Asn Thr Leu Tyr Tyr Val Asn
385 390 395 400
Lys Leu Glu Gly Lys Ala Leu Tyr Ile Lys Gly Glu Pro Ile Ile Asn
405 410 415
Tyr Tyr Asn Pro Leu Val Phe Pro Ser Asp Glu Phe Asp Ala Ser Ile
420 425 430
Ala Gln Val Asn Ala Lys Ile Asn Gln Ser Leu Ala Phe Ile Arg Arg
435 440 445
Ser Asp Glu Leu Leu His
450
Claims (8)
1.一种牛呼吸道胞合体病毒抗原蛋白,编码牛呼吸道胞合体病毒关键蛋白F-蛋白野生种的氨基酸序列为简称SEQ AAL49410.1,具体序列为MRMIISIILISTYVPHITLCQNITEEFYQSTCSAVSRGYLSALRTGWYTSVVTIELSKIQKNVCNGTDSKVKLIKQELERYNNAVVELQSLMQNEPTSSSRAKRGIPESIHYTRNSTKKFYGLMGKKRKRRFLGFLLGIGSAIASGVAVSKVLHLEGEVNKIKNALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDKELLPKVNNHDCRISNIATVIEFQQKNNRLLEIAREFSVNAGITTPLSTYMLTNSELLSIINDMPITNDQKKLMSSNVQIVRQQSYSIMSVVKEEVIAYVVQLPLYGVIDTPCWKLHTSPLCTTDNEEGSNICLTRTDRGWYCDNAGSVSFFPQAETCKVQSNRVFCDTMNSLTLPTDVNLCNTDIFNAKYDCKIMTSKTDISSSVITSIGAIVSCYGKTKCTASNKNRGIIKTFSNGCDYVSNKGVDTVSVGNTLYYVNKLEGKALYIKGEPIINYYNPLVFPSDEFDASIAQVNAKINQSLAFIRRSDELLHSVDVGKSTTNVVITTIIIVIVVVILMLITVGLLFYCKTRSTPIMLGKDQLSSINNLSFSK,其特征在于:所述牛呼吸道胞合体病毒抗原蛋白的氨基酸序列相比SEQ AAL49410.1至少有两个位点被半胱氨酸替代,且替代后的半胱氨酸之间由二硫键连接。
2.根据权利要求1所述的一种牛呼吸道胞合体病毒抗原蛋白,其特征在于:所述位点为氨基酸序列第148位缬氨酸和288位异亮氨酸。
3.根据权利要求1所述的一种牛呼吸道胞合体病毒抗原蛋白,其特征在于:所述位点为氨基酸序列第158位亮氨酸和290位丝氨酸。
4.根据权利要求1中所述的一种牛呼吸道胞合体病毒抗原蛋白,其特征在于:所述牛呼吸道胞合体病毒抗原蛋白的氨基酸序列相比SEQ AAL49410.1,在第260位点的亮氨酸由半胱氨酸替代,并在该位点实现空穴填充。
5.根据权利要求1~3中所述的任一种牛呼吸道胞合体病毒抗原蛋白,其特征在于:所述针对牛呼吸道胞合体病毒抗原蛋白的氨基酸序列剔除SEQ AAL49410.1序列中的103位点至138位点的氨基酸序列,采用sgsgs连接102位点和139位点。
6.根据权利要求1~3中所述的任一种牛呼吸道胞合体病毒抗原蛋白,其特征在于:所述针对牛呼吸道胞合体病毒抗原蛋白的氨基酸序列剔除SEQ AAL49410.1序列中的103位点至142位点的氨基酸序列,采用sgsgs连接102位点和143位点。
7.根据权利要求1~3中所述的任一种牛呼吸道胞合体病毒抗原蛋白,其特征在于:所述编码牛呼吸道胞合体病毒抗原蛋白的氨基酸序列相比SEQ AAL49410.1序列,第99位点天冬氨酸由半胱氨酸替代,第362位点丝氨酸由半胱氨酸替代,并在替代后的半胱氨酸之间连接内二硫键。
8.一种牛呼吸道胞合体病毒抗原蛋白的制备方法,其特征在于:具体工艺如下:
(1)根据结构生物学的原理,进行蛋白结晶,结晶后用X-射线观测,确定侵染病毒关键病原F-蛋白侵染前后的结构变化;
(2)根据步骤(1)结构变化设计出抗原蛋白的序列和结构;
(3)经多种抗原测试和稳定性特性检测确定出需要抗原蛋白的合格性;
(4)将经过验证的抗原蛋白序列进行相应的蛋白合成、表达、提纯和检测,得到用来作为动物试验和临床试验的针对牛呼吸道胞合体病毒抗原蛋白。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611064350.XA CN106397547A (zh) | 2016-11-28 | 2016-11-28 | 一种牛呼吸道胞合体病毒抗原蛋白 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611064350.XA CN106397547A (zh) | 2016-11-28 | 2016-11-28 | 一种牛呼吸道胞合体病毒抗原蛋白 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106397547A true CN106397547A (zh) | 2017-02-15 |
Family
ID=58082315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611064350.XA Pending CN106397547A (zh) | 2016-11-28 | 2016-11-28 | 一种牛呼吸道胞合体病毒抗原蛋白 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106397547A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1264425A (zh) * | 1997-07-17 | 2000-08-23 | 皮埃尔法博赫药品公司 | 用于诊断和治疗的呼吸道合胞病毒表位和含有它们的抗体 |
CN103842374A (zh) * | 2011-05-13 | 2014-06-04 | 诺华股份有限公司 | 融合前的rsv f抗原 |
-
2016
- 2016-11-28 CN CN201611064350.XA patent/CN106397547A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1264425A (zh) * | 1997-07-17 | 2000-08-23 | 皮埃尔法博赫药品公司 | 用于诊断和治疗的呼吸道合胞病毒表位和含有它们的抗体 |
CN103842374A (zh) * | 2011-05-13 | 2014-06-04 | 诺华股份有限公司 | 融合前的rsv f抗原 |
Non-Patent Citations (1)
Title |
---|
YUNUS,A.S.等: "fusion protein [Bovine respiratory syncytial virus ATCC51908]", 《GENBANK DATABSE》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105934441A (zh) | 新型sars免疫原性组合物 | |
CN107022008A (zh) | 广谱地抑制人类冠状病毒感染的多肽及其应用 | |
CN108912215A (zh) | 用于登革病毒表位的方法和组合物 | |
CN104271594B (zh) | 用于初免‑加强疫苗的水疱性口炎病毒 | |
CN108486067B (zh) | 猪流行性腹泻病毒变异株及其制备的灭活疫苗和应用 | |
CN105483140B (zh) | 一种以人复制缺陷腺病毒为载体的埃博拉病毒病疫苗 | |
WO2007068154A1 (en) | A method for preparing specific igy against mutant avian influenza virus and the preparation tηereof | |
WO2019047608A1 (zh) | 一种鸭坦布苏病毒e蛋白截短蛋白及应用 | |
CN104293741A (zh) | 一种呼吸道合胞病毒病毒样颗粒疫苗及其制备方法和应用 | |
ES2524975T3 (es) | Cepa del virus de la fiebre amarilla de alto rendimiento con mayor propagación en células | |
CN114891074A (zh) | 一种季节性甲型流感通用病毒样颗粒及其制备方法与应用 | |
CN102397559B (zh) | 广谱型流感疫苗及其制备方法 | |
CN102464716A (zh) | 一种用于猪、人和蚊子中乙型脑炎病毒抗原检测的elisa试剂盒及应用 | |
CN103193869A (zh) | 一种牛口蹄疫病毒a型合成肽及其制备和应用 | |
Li et al. | B and T cell epitopes of the incursionary foot-and-mouth disease virus serotype SAT2 for vaccine development | |
CN103539839A (zh) | 肠道病毒71型的vp2抗原的中和表位多肽及其用途 | |
CN104096235A (zh) | 一种基因工程热稳定疫苗及其制备方法 | |
Ozkan | How close are we to a COVID-19 vaccine | |
CN106432439A (zh) | 一种牛呼吸道胞合体病毒抗原蛋白 | |
CN102240399B (zh) | 鳜传染性脾肾坏死病毒(isknv)orf093蛋白的应用 | |
CN104353063A (zh) | 预防和控制人呼吸道合胞病毒感染的生物制剂及制备方法 | |
CN106518988A (zh) | 一种牛呼吸道胞合体病毒抗原蛋白 | |
CN106749556A (zh) | 一种牛呼吸道胞合体病毒抗原蛋白 | |
CN103189386B (zh) | 重组人类免疫缺陷病毒(hiv)包膜抗原蛋白和含其的疫苗 | |
CN106397547A (zh) | 一种牛呼吸道胞合体病毒抗原蛋白 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170215 |
|
RJ01 | Rejection of invention patent application after publication |